SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 250 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,621,000 | +31.5% | 77,214 | +0.6% | 0.32% | +29.5% |
| Q1 2018 | $3,514,000 | -41.3% | 76,731 | -48.9% | 0.25% | +26.8% |
| Q4 2017 | $5,986,000 | +102.6% | 150,192 | +103.3% | 0.20% | -2.9% |
| Q3 2017 | $2,955,000 | -10.7% | 73,869 | -43.6% | 0.20% | -18.7% |
| Q4 2016 | $3,308,000 | -2.2% | 130,919 | -4.3% | 0.25% | +11.6% |
| Q3 2016 | $3,382,000 | +21.4% | 136,776 | 0.0% | 0.22% | +16.6% |
| Q2 2016 | $2,786,000 | +40.0% | 136,776 | +4.8% | 0.19% | +33.1% |
| Q1 2016 | $1,990,000 | – | 130,523 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |